US10398776B1 – September 3, 2019 – Phonophoretic cannabidiol composition and transdermal delivery system

Please complete the required fields.




Inventors :

Shamaya Chah; Nicholas Bart Magrone, Sr.

Owner :

Essential Green Goodness LLC

Application Number :

US14930979

Document Number :

US10398776B1

Priority Date :

November 3, 2015

Filing Date :

November 3, 2015

Date of Grant/ Publication :

September 3, 2019

Class :

A61K41 / 00; A61K31 / 05; A61N7 / 00

Abstract

A phonophoretic cannabidiol composition comprises an amount of cannabidiol, an amount of a glucose source, such as honey, an amount of aloe vera, and amounts of one or more of glucosamine, methylsulfonylmethane, and chondroitin. A transdermal delivery system for administration of a phonophoretic cannabidiol composition includes a phonophoretic cannabidiol composition, a laser generator comprising an emitter which generates and directs a laser beam to the treatment area, and an ultrasound generator comprising a transducer which generates and transmits a plurality of ultrasonic waves to the treatment area. A method for transdermal delivery of a phonophoretic cannabidiol composition includes selecting laser pretreatment parameters, directing a laser beam to the treatment area, applying an amount of a phonophoretic cannabidiol composition to a treatment area, selecting ultrasonic treatment parameters, and, transmitting a plurality of ultrasonic waves to the treatment area.

Claim(s)

1. A phonophoretic cannabidiol composition formulated for application to a patient’s skin and transdermal delivery to a portion of the patient’s cartilage in a treatment area, said composition comprising: an amount of cannabidiol, an amount of a glucose source to induce living cells to allow said composition to migrate across the cells and for metabolization therein, an amount of aloe vera to improve permeability of said composition through the patient’s skin and underlying subcutaneous tissue, and an amount of one or more of glucosamine and chondroitin to facilitate regeneration and elasticity of the portion of the patient’s cartilage, and methylsulfonylmethane to reduce inflammation in the treatment area and to provide usable sulfur thereto.

Summary

No Comments

Leave a comment

Sorry, you must be logged in to post a comment. Login